Dergi
/
Biyoloji
/
TGF-β-mediated Endothelial to Mesenchymal Transition (EndMT) and the Functional Assessment of EndMT Effectors using CRISPR/Cas9 Gene Editing
JoVE Journal
Biyoloji
This content is Free Access.
JoVE Journal Biyoloji
TGF-β-mediated Endothelial to Mesenchymal Transition (EndMT) and the Functional Assessment of EndMT Effectors using CRISPR/Cas9 Gene Editing

TGF-β-mediated Endothelial to Mesenchymal Transition (EndMT) and the Functional Assessment of EndMT Effectors using CRISPR/Cas9 Gene Editing

4,653 Views

•

07:05 min

•

February 26, 2021

DOI:

10.3791/62198-v

DOI:
10.3791/62198-v

•

07:05 min
February 26, 2021

•

3 Views
, , ,
1Dept. Cell Chemical Biology,Leiden Üniversitesi Tıp Merkezi, 2Oncode Institute,Leiden Üniversitesi Tıp Merkezi

Özet

Automatically generated

We describe methods to investigate TGF-β2-induced EndMT in endothelial cells by observing cell morphology changes and examining the expression EndMT-related marker changes using immunofluorescence staining. CRISPR/Cas9 gene editing was described and used to deplete the gene encoding Snail to investigate its role in TGF-β2-induced EndMT.

Explore More Videos

Endothelial To Mesenchymal TransitionTGF-betaMesenchymal MarkersCell PermeabilizationImmunofluorescence StainingCRISPR/Cas9 Gene EditingSB-431542DMSOPancreatic Islet Endothelial MS1 CellsCell CultureCell Morphology

Read Article

Cite this Article

Ma, J., van der Zon, G., Sanchez-Duffhues, G., ten Dijke, P. TGF-β-mediated Endothelial to Mesenchymal Transition (EndMT) and the Functional Assessment of EndMT Effectors using CRISPR/Cas9 Gene Editing. J. Vis. Exp. (168), e62198, doi:10.3791/62198 (2021).

Download .ris file

Copy

Share Video

.

Copy